XML 13 R6.htm IDEA: XBRL DOCUMENT v3.25.3
Condensed Consolidated Statements of Shareholders' Equity (Unaudited) - USD ($)
$ in Thousands
Total
Common Stock
Additional Paid In Capital
Accumulated Other Comprehensive Gain (Loss)
Accumulated Deficit
Noncontrolling Interest
Beginning Balance at Dec. 31, 2023 $ 308,278 $ 14 $ 1,452,502 $ 215 $ (1,144,332) $ (121)
Beginning Balance, Shares at Dec. 31, 2023   145,082,271        
Issuance of common stock for cash upon exercise of stock options 114   114      
Issuance of common stock for cash upon exercise of stock options, Shares   65,900        
Vesting of restricted stock units, net   2,413,415        
Share-based compensation expense 40,778   40,778      
Other comprehensive income 282     282    
Net (loss) income (125,878)       (125,800) (78)
Ending Balance at Sep. 30, 2024 223,574 $ 14 1,493,394 497 (1,270,132) (199)
Ending Balance, Shares at Sep. 30, 2024   147,561,586        
Beginning Balance at Jun. 30, 2024 241,430 $ 14 1,479,832 (182) (1,238,061) (173)
Beginning Balance, Shares at Jun. 30, 2024   147,462,201        
Issuance of common stock for cash upon exercise of stock options 40   40      
Issuance of common stock for cash upon exercise of stock options, Shares   20,000        
Vesting of restricted stock units, net   79,385        
Share-based compensation expense 13,522   13,522      
Other comprehensive income 679     679    
Net (loss) income (32,097)       (32,071) (26)
Ending Balance at Sep. 30, 2024 223,574 $ 14 1,493,394 497 (1,270,132) (199)
Ending Balance, Shares at Sep. 30, 2024   147,561,586        
Beginning Balance at Dec. 31, 2024 202,485 $ 14 1,506,353 166 (1,303,824) (224)
Beginning Balance, Shares at Dec. 31, 2024   147,773,744        
Issuance of common stock for cash upon exercise of stock options $ 8,838 $ 1 8,837      
Issuance of common stock for cash upon exercise of stock options, Shares 1,394,132 1,394,132        
Vesting of restricted stock units and market-based restricted stock units   3,413,166        
Share-based compensation expense $ 38,763   38,763      
Other comprehensive income 45     45    
Net (loss) income (45,878)       (45,920) 42
Ending Balance at Sep. 30, 2025 204,253 $ 15 1,553,953 211 (1,349,744) (182)
Ending Balance, Shares at Sep. 30, 2025   152,581,042        
Beginning Balance at Jun. 30, 2025 179,536 $ 15 1,538,919 73 (1,359,290) (181)
Beginning Balance, Shares at Jun. 30, 2025   152,234,772        
Issuance of common stock for cash upon exercise of stock options 1,777   1,777      
Issuance of common stock for cash upon exercise of stock options, Shares   273,428        
Vesting of restricted stock units, net   72,842        
Share-based compensation expense 13,257   13,257      
Other comprehensive income 138     138    
Net (loss) income 9,545       9,546 (1)
Ending Balance at Sep. 30, 2025 $ 204,253 $ 15 $ 1,553,953 $ 211 $ (1,349,744) $ (182)
Ending Balance, Shares at Sep. 30, 2025   152,581,042